Europe

Thermo Fisher opens molecular biology center of excellence in Lithuania

Wednesday, September 26, 2012 11:45 AM

Thermo Fisher Scientific, a global service provider, has officially opened its molecular biology center of excellence in Vilnius, Lithuania. The new facility will provide molecular, protein and cellular biology products to better serve growing demand from life sciences customers throughout Eastern Europe and create new opportunities globally.

More... »

Successful MHRA inspection of Almac’s clinical services U.K. facility

Wednesday, September 26, 2012 11:18 AM

Global service provider Almac passed a successful inspection of its clinical services operations located in Craigavon by the U.K. Medicines and Healthcare products Regulatory Agency (MHRA).

More... »

EMD Millipore opens GMP bioproduction facility in France

Tuesday, September 25, 2012 12:02 PM

EMD Millipore, the Billerica, Mass.-based life science division of Merck, has opened its advanced GMP bioproduction facility in Martillac, France, offering a full, single-use process train to speed a molecule’s journey to the clinic.

More... »

NW Bio appoints vet Rosskamp as CEO of German subsidiary

Friday, September 21, 2012 01:24 PM

Northwest Biotherapeutics, a biotech developing DCVaxR personalized immune therapies for cancer, has appointed former pharmaceutical industry executive Dr. Gunter Rosskamp as the CEO of the company's German subsidiary, Northwest Biotherapeutics, Gmbh.

More... »

Wellington Partners announces first closing of new life science fund

Thursday, September 20, 2012 07:31 AM

Wellington Partners, a pan-European venture capital firm, announced the successful first closing of its new Wellington Partners IV Life Science Fund, which has attracted commitments from investors of $91 million.

More... »

CureVac secures $104M in Series D financing

Wednesday, September 19, 2012 12:04 PM

CureVac, a German clinical stage biopharmaceutical company developing a new class of therapies and vaccines based on mRNA, today announced the completion of a $140 million financing round with its main investor, dievini Hopp BioTech Holding.

More... »

Mutabilis receives $5.2M from E.U. for HIVINNOV project

Wednesday, September 19, 2012 11:06 AM

Mutabilis, a spin-off from INSERM that focuses on therapeutics for treating serious, hospital-acquired infections, has received $5.2 million of European funding for the HIVINNOV project, aimed at developing new antiretrovirals against HIV.

More... »

UCB expands biotechnology base in Belgium

Monday, September 17, 2012 02:02 PM

In line with its strategy, and in preparation for the growing demand for biological medicines, UCB, a biopharma focused on the central nervous system and immune system, has opened its new pilot biotechnology plant at its Braine-L’Alleud site in Belgium.

More... »

Sartorius opens German production facility for bioreactors

Friday, September 14, 2012 12:19 PM

Sartorius, the Germany-based international laboratory and process technology provider, has officially opened its new plant in Guxhagen, Germany, for the manufacture of bioreactors.

More... »

Oncodesign, Sanofi ink research collaboration and license agreement

Friday, September 14, 2012 11:57 AM

Oncodesign, a French drug discovery company and oncology pharmacology service provider, has entered into a strategic research collaboration with global healthcare company Sanofi to apply Oncodesign's Nanocyclix technology to Sanofi kinase target programs.

More... »